Adam Kaplin

Adam Kaplin

Plus aucun poste en cours
59 ans
Consumer Services
Health Technology
Health Services

Profil

Adam Kaplin was the founder of MIRA Pharmaceuticals, Inc., founded in 2020, where the title held was President & Chief Science Officer from 2022 to 2024.
Dr. Kaplin is also the founder of Nousynapse Pharmaceuticals..
Dr. Kaplin is currently the Director-Johns Hopkins Ketamine Clinic at The Johns Hopkins University since 2002.
Dr. Kaplin is also currently the Director at Cody Unser First Step Foundation since 2005.
Formerly, Dr. Kaplin was Chief Scientific Officer at Q from 2020 to 2024.
Education includes a doctorate from The Johns Hopkins University conferred in 1996 and an undergraduate degree from Yale University conferred in 1988.

Postes actifs de Adam Kaplin

SociétésPosteDébut
Corporate Officer/Principal 01/01/2002
Directeur/Membre du Conseil 01/01/2005

Anciens postes connus de Adam Kaplin

SociétésPosteFin
Q/C TECHNOLOGIES, INC. Directeur Technique/Scientifique/R&D 15/04/2024
MIRA PHARMACEUTICALS, INC. Fondateur 07/03/2024
Voir l'expérience en détail de Adam Kaplin

Formation de Adam Kaplin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

94

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées5

Consumer Services

Consumer Services

Health Technology

Health Services

Health Technology

  1. Bourse
  2. Insiders
  3. Adam Kaplin
🔇